Inhaled Nintedanib (AP02) for the Treatment of IPF: Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses to Healthy Subjects and IPF Patients

Michelle Palacios, Stephen Pham, Mark Surber, Deepthi K. Nair, Felix A. Woodhead